Dapagliflozin or Empagliflozin: Clinical Trials

1 trial of Dapagliflozin or Empagliflozin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Dapagliflozin or Empagliflozin: new trials by email Literature Review of Dapagliflozin or Empagliflozin trials Research Report on Dapagliflozin or Empagliflozin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
Enavogliflozin, Dapagliflozin or Empagliflozin - Diabetes Mellitus, Type 2, Cardiovascular Diseases
Phase 4RecruitingYonsei University28622024-01-222024-10-15

Conditions studied

Cardiovascular Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Kidney Diseases (1)

Sponsors

Yonsei University (1)

Countries

South Korea (1)